Misonix Takes (Tinnitus) Step Forward in Ultrasonic Hearing Aid Market
Misonix Takes Step Forward in Ultrasonic Hearing Aid Market
[Press Release] PR Newswire via Yahoo! Finance - Oct 19 5:17 AM
Misonix, Inc. , a developer of ultrasonic medical device technology for the treatment of cancer and other healthcare purposes, today announced that it has contracted Ceres Biotechnology, LLC for services to assist in brining to market its ultrasonic medical devices for those with severe hearing impairment.Save to My Web
HYZAAR(R) 100-12.5 mg Offers A New Convenient Dosing Option Within The Losartan Family
[Press Release] Business Wire via Yahoo! Finance - Oct 21 5:30 AM
Merck & Co., Inc., today announced the availability of HYZAAR 100-12.5 mg , a new tablet that combines the once-daily efficacy of 100 mg COZAAR with a low-dose diuretic to provide greater convenience and enhance titration options within the losartan family.Save to My Web
